NDC 55566-1010

Fyremadel

Ganirelix Acetate

Fyremadel is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is Ganirelix Acetate.

• Product ID: 55566-1010_4f2833c9-d086-43c5-83d3-17d9986a7a3e
• NDC: 55566-1010
• Product Type: Human Prescription Drug
• Proprietary Name: Fyremadel
• Generic Name: Ganirelix Acetate
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-12-14
• Marketing Category: ANDA /
• Application Number: ANDA204246
• Labeler Name: Ferring Pharmaceuticals Inc.
• Substance Name: GANIRELIX ACETATE
• Active Ingredient Strength: 250 ug/.5mL
• Pharm Classes: Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Receptor Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 55566-1010-1

1 BLISTER PACK in 1 CARTON (55566-1010-1) > 1 SYRINGE in 1 BLISTER PACK > .5 mL in 1 SYRINGE

• Marketing Start Date: 2021-12-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Fyremadel" or generic name "Ganirelix Acetate"

NDC	Brand Name	Generic Name
55566-1010	Fyremadel	ganirelix acetate
0052-0301	Ganirelix Acetate	Ganirelix Acetate
0548-5001	Ganirelix Acetate	Ganirelix Acetate
55566-1000	Ganirelix Acetate	Ganirelix Acetate
62756-072	Ganirelix Acetate	Ganirelix Acetate
71288-554	Ganirelix Acetate	Ganirelix Acetate
78206-138	Ganirelix Acetate	Ganirelix Acetate